Novel effects of nitric oxide

Annual Review of Pharmacology and Toxicology

Volumn 41, Issue , 2001, Pages 203-236

  Davis, K L ^a   Martin, E ^a   Turko, I V ^a   Murad, F ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Nitration; Nitrosylation; Reactive nitrogen species

Indexed keywords

GUANYLATE CYCLASE; METAL; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; CELL SURVIVAL; CHEMICAL INTERACTION; DRUG EFFECT; HUMAN; LIPID METABOLISM; NITRATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

NASA DISCIPLINE CARDIOPULMONARY; NON-NASA CENTER;

ANIMALS; HUMANS; METALS; NITRIC OXIDE; PROTEINS;

EID: 0035035184     PISSN: 03621642     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.pharmtox.41.1.203     Document Type: Review

References (218)

1. The 1996 Albert Lasker Medical Research Awards. Signal transduction using nitric oxide and cyclic guanosine monophosphate
2. NO at work
3. Nitric oxide synthase: Aspects concerning structure and catalysis
4. Nitric oxide in arthritis
5. Extensive tyrosine nitration in human myocardial inflammation: Evidence for the presence of peroxynitrite
6. High nitric oxide synthase activity in endothelial cells in ulcerative colitis
7. The selective beneficial effects of nitric oxide inhibition in experimental colitis
8. Nitric oxide in interstitial nephritis and other autoimmune diseases
9. Induction of nitrotyrosine-like immunoreactivity in the lower motor neuron of amyotrophic lateral sclerosis
10. The multifaceted roles of nitric oxide in cancer
11. Role of nitric oxide in cancer biology
12. Nitric oxide and vascular responses in type I diabetes
13. Aspects of the involvement of interleukin-1 and nitric oxide in the pathogenesis of insulin-dependent diabetes mellitus
14. Nitric oxide-mediated mitochondrial damage in the brain: Mechanisms and implications for neurodegenerative diseases
15. The role of mitochondrial dysfunction and neuronal nitric oxide in animal models of neurodegenerative diseases
16. Chemical biology of nitric oxide: Insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide
17. Nitric oxide. I. Physiological chemistry of nitric oxide and its metabolites: Implications in inflammation
18. Cellular signaling with nitric oxide and cyclic guanosine monophosphate
19. Inhibition of cytochromes P450 by nitric oxide and a nitric oxide-releasing agent
20. Autoxidation kinetics of aqueous nitric oxide
21. • solutions; the nature of the nitrosating intermediates
22. 2 within the hydrophobic interior of biological membranes
23. Diffusion of nitric oxide in the aorta wall monitored in situ by prophyrinic microsensors
24. The reaction of NO with superoxide
25. Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation. Formation of novel nitrogen-containing oxidized lipid derivatives
26. Nitric oxide-stimulated guanine nucleotide exchange on p21ras
27. Activation of the cardiac calcium release channel (ryanodine receptor) by poly-S-nitrosylation
28. (S)NO signals: Translocation, regulation, and a consensus motif
29. N-methyl-D-aspartic acid receptor structure and function
30. Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain
31. Localization of nitric oxide synthase indicating a neural role for nitric oxide
32. Nitric oxide synthase activity endogenously modulates NMDA receptors
33. Molecular basis of NMDA receptor-coupled ion channel modulation by S-nitrosylation
34. Excitatory amino acids as a final common pathway for neurologic disorders
35. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds
36. Direct activation of the olfactory cyclic nucleotidegated channel through modification of sulfhydryl groups by NO compounds
37. A single intracellular cysteine residue is responsible for the activation of the olfactory cyclic nucleotide-gated channel by NO
38. A molecular redox switch on p21(ras). Structural basis for the nitric oxide-p21 (ras) interaction
39. Sarcoma viruses carrying ras oncogenes induce differentiation-associated properties in a neuronal cell line
40. Microinjection of the ras oncogene protein into PC12 cells induces morphological differentiation
41. Involvement of ras p21 in neurotrophin-induced response of sensory, but not sympathetic neurons
42. Effect of a dominant inhibitory Ha-ras mutation on neuronal differentiation of PC12 cells
43. Activation of c-Ha-Ras by nitric oxide modulates survival responsiveness in neuronal PC12 cells
44. Nitric oxide reversibly inhibits seven members of the caspase family via S-nitrosylation
45. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis
46. Nitric oxide prevents IL-1beta and IFN-gamma-inducing factor (IL-18) release from macrophages by inhibiting caspase-1 (IL-1beta-converting enzyme)
47. Suppression of apoptosis by nitric oxide via inhibition of interleukin-1beta-converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases
48. Fas-induced caspase denitrosylation
49. Nitric oxide inhibits Fas-induced apoptosis
50. Nitric oxide-induced S-nitrosylation of glyceraldehyde-3-phosphate dehydrogenase inhibits enzymatic activity and increases endogenous ADP-ribosylation
51. Posttranslational modification of glyceraldehyde-3-phosphate dehydrogenase by S-nitrosylation and subsequent NADH attachment
52. Redox signaling: Nitrosylation and related target interactions of nitric oxide
53. 2+-ATPase in skeletal muscle
54. An activity in rat tissues that modifies nitrotyrosine-containing proteins
55. Effects of peroxynitrite-induced protein modifications on tyrosine phosphorylation and degradation
56. Kinetics of superoxide dismutase- and iron-catalyzed nitration of phenolics by peroxynitrite
57. Peroxynitrite formation from macrophage-derived nitric oxide
58. Nitric oxide and superoxide contribute to motor neuron apoptosis induced by trophic factor deprivation
59. Lack of tyrosine nitration by peroxynitrite generated at physiological pH
60. Superoxide reacts with nitric oxide to nitrate tyrosine at physiological pH via peroxynitrite
61. Tyrosine nitration by peroxynitrite formed from nitric oxide and superoxide generated by xanthine oxidase
62. Oxidative chemistry of nitric oxide: The roles of superoxide, peroxynitrite, and carbon dioxide
63. Pathophysiology of nitric oxide and related species: Free radical reactions and modification of biomolecules
64. Formation of nitrating and chlorinating species by reaction of nitrite with hypochlorous acid. A novel mechanism for nitric oxide-mediated protein modification
65. Eosinophil peroxidase nitrates protein tyrosyl residues. Implications for oxidative damage by nitrating intermediates in eosinophilic inflammatory disorders
66. Nitrite as a substrate and inhibitor of myeloperoxidase. Implications for nitration and hypochlorous acid production at sites of inflammation
67. Nitric oxide trapping of the tyrosyl radical of prostaglandin H synthase-2 leads to tyrosine iminoxyl radical and nitrotyrosine formation
68. Ribonucleotide reductase - A radical enzyme
69. Tyrosine radicals are involved in the photosynthetic oxygen-evolving system
70. Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and ugly
71. Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite
72. Nitration and inactivation of manganese superoxide dismutase in chronic rejection of human renal allografts
73. Clinical evidence of peroxynitrite formation in chronic renal failure patients with septic shock
74. Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease
75. Evidence for nitric oxide-mediated oxidative damage in chronic inflammation. Nitrotyrosine in serum and synovial fluid from rheumatoid patients
76. Nitrotyrosine residues in placenta. Evidence of peroxynitrite formation and action
77. iNOS expression and nitrotyrosine formation in the myocardium in response to inflammation is controlled by the interferon regulatory transcription factor 1
78. Nitric oxide contributes to the progression of myocardial damage in experimental autoimmune myocarditis in rats
79. Nitrotyrosine formation with endotoxin-induced kidney injury detected by immunohistochemistry
80. Immunohistochemically detected protein nitration indicates sites of renal nitric oxide release in Goldblatt hypertension
81. In-activation of tyrosine hydroxylase by nitration following exposure to peroxynitrite and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
82. Elevated free nitrotyrosine levels, but not proteinbound nitrotyrosine or hydroxyl radicals, throughout amyotrophic lateral sclerosis (ALS)-like disease implicate tyrosine nitration as an aberrant in vivo property of one familial ALS-linked superoxide dismutase 1 mutant
83. Interleukin 1beta decreases prostacyclin syntase activity in rat mesangial cells via endogenous peroxynitrite formation
84. Selective nitration of prostacyclin synthase and defective vasorelaxation in atherosclerotic bovine coronary arteries
85. Tyrosine nitration as a mechanism of selective inactivation of prostacyclin synthase by peroxynitrite
86. Inactivation of human manganese-superoxide dismutase by peroxynitrite is caused by exclusive nitration of tyrosine 34 to 3-nitrotyrosine
87. Nitration of the low molecular weight neurofilament is equivalent in sporadic amyotrophic lateral sclerosis and control cervical spinal cord
88. Role of SOD-1 and nitric oxide/cyclic GMP cascade on neurofilament aggregation in ALS/MND
89. The oxidative inactivation of sarcoplasmic reticulum Ca(2+)-ATPase by peroxynitrite
90. Quantitation of nitrotyrosine levels in lung sections of patients and animals with acute lung injury
91. Nitration of surfactant protein A (SP-A) tyrosine residues results in decreased mannose binding ability
92. Identification of nitration sites on surfactant protein A by tandem electrospray mass spectrometry
93. Increased formation of the potent oxidant peroxynitrite in the airways of asthmatic patients is associated with induction of nitric oxide synthase: Effect of inhaled glucocorticoid
94. Peroxynitrite disables the tyrosine phosphorylation regulatory mechanism: Lymphocyte-specific tyrosine kinase fails to phosphorylate nitrated cdc2(6-20)NH2 peptide
95. Tyrosine nitration of c-SRC tyrosine kinase in human pancreatic ductal adenocarcinoma
96. Peroxynitrite induces tryosine nitration and modulates tyrosine phosphorylation of synaptic proteins
97. Reactions of nitric oxide with metalloproteins
98. Kinetics of nitric oxide dissociation from five- and six-coordinate nitrosyl hemes and heme proteins, including soluble guanylate cyclase
99. Soluble guanylate cyclase from bovine lung: Activation with nitric oxide and carbon monoxide and spectral characterization of the ferrous and ferric states
100. Purified soluble guanylyl cyclase expressed in a baculovirus/Sf9 system: Stimulation by YC-1, nitric oxide, and carbon monoxide
101. Dissociation of nitric oxide from soluble guanylate cyclase
102. Spectral and kinetic studies on the activation of soluble guanylate cyclase by nitric oxide
103. Nitric oxide and iron proteins
104. Studies of the heme coordination and ligand binding properties of soluble guanylyl cyclase (sGC): Characterization of Fe(II)sGC and Fe(II)sGC(CO) by electronic absorption and magnetic circular dichroism spectroscopies and failure of CO to activate the enzyme
105. Effects of GTP on bound nitric oxide of soluble guanylate cyclase probed by resonance Raman spectroscopy
106. Endothelin increases cyclic GMP levels in LLC-PK1 porcine kidney epithelial cells via formation of an endothelium-derived relaxing factor-like substance
107. Nitric oxide potently and reversibly deenergizes mitochondria at low oxygen tension
108. Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases
109. Nanomolar concentrations of nitric oxide reversibly inhibit synaptosomal respiration by competing with oxygen at cytochrome oxidase
110. Studies of the primary oxygen intermediate in the reaction of fully reduced cytochrome oxidase
111. On the mechanism of inhibition of cytochrome c oxidase by nitric oxide
112. Inhibition of cytochrome c oxidase in turnover by nitric oxide: Mechanism and implications for control of respiration
113. Reactivity of nitric oxide with cytochrome c oxidase: Interactions with the binuclear centre and mechanism of inhibition
114. Nitrosyl cytochrome c oxidase. Formation and properties of mixed valence enzyme
115. Role of nitric oxide in the control of mitochondrial function
116. Photochemistry of the nitric ode adduct of water soluble iron(III) porphrin and ferrihemoproteins studied by nanosecond laser photolysis
117. Reversible binding and inhibition of catalase by nitric oxide
118. The effect of various nitric oxide-donor agents on hydrogen peroxide-mediated toxicity: A direct correlation between nitric oxide formation and protection
119. Nitric oxide and intracellular heme
120. Injury of neoplastic cells by murine macrophages leads to inhibition of mitochondrial respiration
121. Sites of inhibition of mitochondrial electron transport in macrophage-injured neoplastic cells
122. Differentiation of murine macrophages to express nonspecific cytotoxicity for tumor cells results in L-arginine-dependent inhibition of mitochondrial iron-sulfur enzymes in the macrophage effector cells
123. Murine cytotoxic activated macrophages inhibit aconitase in tumor cells. Inhibition involves the iron-sulfur prosthetic group and is reversible
124. The aconitase family: Three structural variations on a common theme
125. IFN-gamma-activated macrophages: Detection by electron paramagnetic resonance of complexes between L-arginine-derived nitric oxide and non-heme iron proteins
126. Regulating the fate of mRNA: The control of cellular iron metabolism
127. Targeting mRNA to regulate iron and oxygen metabolism
128. Iron regulatory protein prevents binding of the 43S translation pre-initiation complex to ferritin and eALAS mRNAs
129. Evidence that the pathway of transferrin receptor mRNA degradation involves an endonucleolytic cleavage within the 3′ UTR and does not involve poly(A) tail shortening
130. Cellular regulation of the iron-responsive element binding protein: Disassembly of the cubane iron-sulfur cluster results in high-affinity RNA binding
131. Biosynthesis of nitric oxide activates iron regulatory factor in macrophages
132. Translational regulation via iron-responsive elements by the nitric oxide/NO-synthase pathway
133. Nitrosative and oxidative modulation of iron regulatory proteins
134. Activation by nitric oxide of an oxidative-stress response that defends Escherichia coli against activated macrophages
135. Direct nitric oxide signal transduction via nitrosylation of iron-sulfur centers in the SoxR transcription activator
136. An iron-sulfur center essential for transcriptional activation by the redox-sensing SoxR protein
137. SoxR, a [2Fe-2S] transcription factor, is active only in its oxidized form
138. Genetic responses against nitric oxide toxicity
139. Identification of the EPR-active iron-nitrosyl complexes in mammalian ferritins
140. Metallothionein reacts with Fe2+ and NO to form products with A g = 2.039 ESR signal
141. The Fpg potein, a DNA repair enzyme, is inhibited by the biomediator nitric oxide in vitro and in vivo
142. High-resolution localization of 69 potential human zinc finger protein genes: A number are clustered
143. Zinc-finger proteins: The classical zinc finger emerges in contemporary plant science
144. In-activation of zinc finger transcription factors provides a mechanism for a gene regulatory role of nitric oxide
145. Crystal structure of a p53 tumor suppressor-DNA complex: Understanding tumorigenic mutations
146. p53 and vascular endothelial growth factor regulate tumor growth of NOS2-expressing human carcinoma cells
147. Nitric oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase expression by wild-type p53
148. Nitric oxide induces conformational and functional modifications of wild-type p53 tumor suppressor protein
149. Protein-radical enzymes
150. The three-dimensional structure of mammalian ribonucleotide reductase protein R2 reveals a more-accessible iron-radical site than Escherichia coli R2
151. Three-dimensional structure of the free radical protein of ribonucleotide reductase
152. Magnetic interaction between the tyrosyl free radical and the antiferromagnetically coupled iron center in ribonucleotide reductase
153. Inhibition of ribonucleotide reductase by nitric oxide derived from thionitrites: Reversible modifications of both subunits
154. Alterations of ribonucleotide reductase activity following induction of the nitrite-generating pathway in adenocarcinoma cells
155. Inactivation of ribonucleotide reductase by nitric oxide
156. Quenching of the tyrosyl free radical of ribonucleotide reductase by nitric oxide. Relationship to cytostasis induced in tumor cells by cytotoxic macrophages
157. Differential sensitivity of the tyrosyl radical of mouse ribonucleotide reductase to nitric oxide and peroxynitrite
158. Higher oxidation states of prostaglandin H synthase. EPR study of a transient tyrosyl radical in the enzyme during the peroxidase reaction
159. Spectroscopic evidence for reaction of prostaglandin H synthase-1 tyrosyl radical with arachidonic acid
160. Structural characterization of arachidonyl radicals formed by prostaglandin H synthase-2 and prostaglandin H synthase-1 reconstituted with mangano protoporphyrin IX
161. Nitric oxide trapping of tyrosyl radicals generated during prostaglandin endoperoxide synthase turnover. Detection of the radical derivative of tyrosine 385
162. Nitric oxide donors activate the cyclo-oxygenase and peroxidase activities of prostaglandin H synthase
163. Regulation of prostaglandin H2 synthase activity by nitrogen oxides
164. The chemistry of DNA damage from nitric oxide and peroxynitrite
165. Oxygen and nitrogen are pro-carcinogens. Damage to DNA by reactive oxygen, chlorine and nitrogen species: Measurement, mechanism and the effects of nutrition
166. Mechanisms of DNA oxidation
167. The physiological and pathophysiological chemistry of nitric oxide
168. Peroxynitrite rapidly permeates phospholipid membranes
169. Quantitation of 8-oxoguanine and strand breaks produced by four oxidizing agents
170. Competitive reactions of peroxynitrite with 2′-deoxyguanosine and 7,8-dihydro-8-oxo-2′-deoxyguanosine (8-oxodG): Relevance to the formation of 8-oxodG in DNA exposed to peroxynitrite
171. Peroxynitrite-induced reactions of synthetic oligonucleotides containing 8-oxoguanine
172. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils
173. DNA damage induced by peroxynitrite: Subsequent biological effects
174. Mutagenesis by apurinic/apyrimidinic sites
175. Purification and properties of mitochondrial uracil-DNA glycosylase from rat liver
176. Damage to the DNA bases in mammalian chromatin by hydrogen peroxide in the presence of ferric and cupric ions
177. Hydroxyl free radical adduct of deoxyguanosine: Sensitive detection and mechanisms of formation
178. The role of 8-hydroxyguanine in carcinogenesis
179. Oxidative DNA and RNA damage in the livers of Sprague-Dawley rats treated with the hepatocarcinogen 2-nitropropane
180. Formation of 8-hydroxydeoxyguanosine (8-OH-dG) in rat kidney DNA after intraperitoneal administration of ferric nitrilotriacetate (Fe-NTA)
181. Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism
182. Frequent nitric oxide synthase-2 expression in human colon adenomas: Implication for tumor angiogenesis and colon cancer progression
183. Synergistic induction of DNA strand breakage by catechol-estrogen and nitric oxide: Implications for hormonal carcinogenesis
184. Inducible nitric oxide synthase, nitrotyrosine, and apoptosis in Helicobacter pylori gastritis: Effect of antibiotics and antioxidants
185. Transition mutation in codon 248 of the p53 tumor suppressor gene induced by reactive oxygen species and a nitric oxide-releasing compound
186. Oxidative stress and mitochondrial DNA mutations in human aging
187. Evidence that the mitochondrial genome is the thrifty genome
188. Endothelial type nitric oxide synthase in skeletal muscle fibers: Mitochondrial relationships
189. Mitochondrial nitric oxide synthase: A ubiquitous regulator of oxidative phosphorylation?
190. Production of nitric oxide by mitochondria
191. Purification and characterization of a nitric-oxide synthase from rat liver mitochondria
192. The role of glutathione in the transport and catabolism of nitric oxide
193. Reactions of nitric oxide with mitochondrial cytochrome c: A novel mechanism for the formation of nitroxyl anion and peroxynitrite
194. Fragmented mitochondrial DNA is the predominant carrier of oxidized DNA bases
195. Nitration of unsaturated fatty acids by nitric oxide-derived reactive species
196. Nitric oxide inhibition of lipoxygenase-dependent liposome and low-density lipoprotein oxidation: Termination of radical chain propagation reactions and formation of nitrogen-containing oxidized lipid derivatives
197. The reaction of low levels of nitrogen dioxide with methyl linoleate in the presence and absence of oxygen
198. Diffusion of peroxynitrite across erythrocyte membranes
199. Accelerated reaction of nitric oxide with O2 within the hydrophobic interior of biological membranes
200. Reactive oxygen species as cellular messengers
201. Effect of cholesterol on the water permeability of thin lipid membranes
202. Peroxynitrite-mediated decarboxylation of pyruvate to both carbon dioxide and carbon dioxide radical anion
203. Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro
204. 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima
205. Chlorination of taurine by human neutrophils. Evidence for hypochlorous acid generation
206. Peroxynitrite: An endogenous oxidizing and nitrating agent
207. The kinetics of the oxidation of L-ascorbic acid by peroxynitrite
208. Stopped-flow kinetic study of the reaction of ascorbic acid with peroxynitrite
209. Nitrosation of uric acid by peroxynitrite, formation of a vasoactive nitric oxide donor
210. Bilirubin is an effective antioxidant of peroxynitrite-mediated protein oxidation in human blood plasma
211. Gamma-tocopherol traps mutagenic electrophiles such as NO(X) and complements alpha-tocopherol: Physiological implications
212. Oxidation and nitration of catecholamines by nitrogen oxides derived from nitric oxide
213. Peroxynitrite scavenging by flavonoids
214. Melatonin is a scavenger of peroxynitrite
215. A new pathway of nitric oxide/cyclic GMP signaling involving S-nitrosoglutathione
216. Beta-carotene effectively scavenges toxic nitrogen oxides: Nitrogen dioxide and peroxynitrous acid
217. Peroxynitrite-induced hemolysis of human erythrocytes and its inhibition by antioxidants
218. The formation of nitric oxide donors from peroxynitrite